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E-mail address:mathias.brochhausen@ifomis.uni-sObjective: This paper introduces the objectives, methods and results of ontology development in the EU
co-funded project Advancing Clinico-genomic Trials on Cancer – Open Grid Services for Improving Med-
ical Knowledge Discovery (ACGT). While the available data in the life sciences has recently grown both in
amount and quality, the full exploitation of it is being hindered by the use of different underlying tech-
nologies, coding systems, category schemes and reporting methods on the part of different research
groups. The goal of the ACGT project is to contribute to the resolution of these problems by developing
an ontology-driven, semantic grid services infrastructure that will enable efﬁcient execution of discov-
ery-driven scientiﬁc workﬂows in the context of multi-centric, post-genomic clinical trials. The focus
of the present paper is the ACGT Master Ontology (MO). Methods: ACGT project researchers undertook
a systematic review of existing domain and upper-level ontologies, as well as of existing ontology design
software, implementation methods, and end-user interfaces. This included the careful study of best prac-
tices, design principles and evaluation methods for ontology design, maintenance, implementation, and
versioning, as well as for use on the part of domain experts and clinicians. Results: To date, the results of
the ACGT project include (i) the development of a master ontology (the ACGT-MO) based on clearly
deﬁned principles of ontology development and evaluation; (ii) the development of a technical infra-
structure (the ACGT Platform) that implements the ACGT-MO utilizing independent tools, components
and resources that have been developed based on open architectural standards, and which includes an
application updating and evolving the ontology efﬁciently in response to end-user needs; and (iii) the
development of an Ontology-based Trial Management Application (ObTiMA) that integrates the ACGT-
MO into the design process of clinical trials in order to guarantee automatic semantic integration without
the need to perform a separate mapping process.
 2010 Elsevier Inc. All rights reserved.1. Introduction
Life sciences are currently at the center of an information revo-
lution. The development of new techniques and tools is making
possible the collection and organization of biological information
at an unprecedented level of detail and in extremely large quanti-
ties. With respect to cancer research, the use of high-throughput
technologies has resulted in an explosion of information and
knowledge about cancers and their treatment. Because it is all rights reserved.
aarland.de (M. Brochhausen).complex multifactorial disease group that affects a signiﬁcant por-
tion of the population worldwide, cancer is a prime target for
focused multidisciplinary efforts using these new and powerful
technologies [1].
However, the lack of an open and shared information infrastruc-
ture is preventing clinical research institutions from being able to
mine and analyze disparate data sources. Our inability to share
technologies and data that have been developed by different orga-
nizations is severely hampering the research process. As a result,
very few cross-site studies and multi-center clinical trials are being
performed. In addition to this, it has proven to be impossible in
most cases to seamlessly integrate data acquired from multiple
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on the molecular elements of cancer with those focused on what
happens at the level of organs, and those that focus on the entire
individual).
The vision of the ACGT project (Advancing Clinico-genomic Tri-
als on Cancer – Open Grid Services for Improving Medical Knowl-
edge Discovery) is to contribute to the resolution of these
problems by developing an ontology-driven, semantic grid services
infrastructure that will enable efﬁcient execution of discovery-dri-
ven analytical workﬂows in the context of multi-centric, post-
genomic clinical trials. The ultimate objective of the ACGT project
is the development of a secure semantic grid services infrastruc-
ture which will (a) facilitate seamless and secure access to hetero-
geneous, distributed multilevel databases; (b) provide a range of
semantically rich re-usable, open tools for the analysis of such inte-
grated, multilevel clinico-genomic data; (c) achieve these results in
the context of discovery-driven (eScience) workﬂows and dynamic
VOs; and (d) fulﬁll these objectives while complying with existing
ethical and legal regulations.
In this paper we focus on the ACGT Master Ontology, the prin-
ciples that guided its development, and the strategies employed for
its evaluation and maintenance. We will present in detail the var-
ious ways in which the ontology has been utilized to address spe-
ciﬁc problems, such as semantic data integration by means of a
mediator tool and the development of an open-source Ontology-
based Trial Management Application.2. The ACGT Master Ontology
2.1. Technical details
The ACGTMaster Ontology (ACGT-MO) is implemented in OWL-
DL,1 the description-logics based subtype of the Web Ontology Lan-
guage (OWL) [2] and can be freely downloaded from http://www.i-
fomis.org/acgt.
The initial development or beta version of the ACGT-MO was
published in June 2007 and it has been further expanded since that
time in order to integrate and respond to the needs of users, both
clinical and technical. The developers are nowworking toward ver-
sion 1.0. At themoment the ontology contains 1667 classes, 288 ob-
ject properties, 15 data properties and 61 individuals. An ontology
of this size is difﬁcult to present in its entirety in a journal paper.
Therefore, we have limited ourselves here to providing ﬁgures con-
taining selected details of the ontology (Figs. 1–7). For the interested
reader, the complete owl-ﬁle of the ACGT-MO can be downloaded,
accessed and viewed freely from http://www.ifomis.org/acgt/1.0.
The ontology has been freely available since it was ﬁrst pub-
lished on the Internet in 2007 and comments and criticism of do-
main and ontology experts has been and is still invited.
There is currently an effort to reduce the number of object prop-
erties by around 60%. The reasons for this effort are both practical
and principled. Practically speaking, it has become clear that 288
object properties are too many for most end-users to keep track
of and utilize efﬁciently. On the other hand, from the standpoint
of the ontology itself there are a number of redundant object prop-
erties, for instance undergoes_Process and undergoes_MedicalPro-
cess, which considerations of simplicity and economy recommend
eliminating wherever possible.2.2. Scope
The ACGT-MO developers set out to comprehensively represent
the domain of cancer research and management, with special1 Current level of DL expressivity is SROIQ(D).emphasis on mammary carcinoma (‘‘breast cancer”), Wilms’ tumor
(nephroblastoma) and rhabdoid tumor. The development of the
MOwas guided and reviewed by researchers from two pre-existing
clinical trials, namely a breast cancer-related trial on Topoisomer-
ase II Alpha Gene Ampliﬁcation and Protein Overexpression Pre-
dicting Efﬁcacy of Epirubicin (TOP) [3] and ‘‘Nephroblastoma
(Wilms’ Tumor) – Clinical Trial and Study SIOP 2001” by the Inter-
national Society of Paediatric Oncology [4]. In order to achieve the
aim of supporting uniﬁed data annotation for these trials, the
developers had to shape the MO as a cross-section of a multitude
of sub-domains, all of which are vitally important to clinical cancer
management and research. In effect, the outcome of this effort is
best seen, not as a comprehensive domain ontology, but rather as
an application ontology tailored to the needs of the ACGT software
system, and as functionally-driven toward the services to be de-
scribed in Section 6 below. A domain ontology is an ontology that
has a clear-cut and distinguishable subject matter, one uniﬁed by
the kinds of objects that it contains, by the dominance of a partic-
ular set of concepts and distinctions pertinent to these objects, and
often by certain characteristic methods of inquiry as well. Para-
digm examples of domain ontologies include representations of
basic scientiﬁc subject matters, such as anatomy, cytology, the dif-
ferent areas of genetics, etc. The ACGT-MO, by contrast, tackles a
mixed bag of aspects arising from clinical cancer management
and cancer research. As a result of this, a single clearly delineated
domain to which the ACGT-MO applies cannot be easily identiﬁed.
The MO, for instance, must represent administrative issues, as well
as therapy- and laboratory-related facets of cancer in clinical real-
ity. In designing it to do this we have been cautious to avoid the
problem of use-mention mistakes that often occur in medical
information systems. The use-mention distinction is violated when
discourse that is intended to be about an object or kind of thing is
phrased in such a way that it refers to the linguistic term for that
thing rather than the thing itself. Consider the following two
sentences:
(1) Neoplasm is synonymous with tumor.
(2) A neoplasm can be both, malign or benign.
The ﬁrst statement is not a statement about neoplasms at all
but rather a statement about the term ‘‘Neoplasm”, whereas the
second is really a statement about actual things, namely neo-
plasms. Correctly formulated, (1) should be written as follows
‘‘Neoplasm” is synonymous with ‘‘tumor”. This example might
seem relatively obvious, but in complex medical information sys-
tems statements about terms are quite often confused with or
substituted for statements about the things in reality that the
terms are intended to refer to. If an information system does not
contain a sharp distinction between sentences of type one and type
two, then consider what would happen if the system containing
the above two sentences also contained the information: Neoplasm
is a word. This would permit inference to the conclusion that there
is some word that is either malign or benign, which is either false
or, if true, not true in the same sense in which a neoplasm is malign
or benign. So, a single use-mention confusion introduces either fal-
sity or ambiguity into the information system, while many such
confusions could truly compromise the overall quality of the data
the system contains.
Thus, for the development of the ACGT-MO it was crucial to
avoid this kind of mistake, especially since we needed to repre-
sent both the clinical reality and the various kinds of documenta-
tion of clinical reality in the domain of our research. In order to
guarantee this, our ontology includes a class called acgt:Informa-
tionObject, which includes items such as reports about entities,
identiﬁers of entities and so on. ACGT is an extension of an Upper
Ontology, namely Basic Formal Ontology (BFO) and we choose to
Fig. 1. Relations between speciﬁc information objects (Medical Image, Diagnosis) and processes, independent and other dependent continuants.
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dentContinuant. A bfo:GenericallyDependentContinuant is deﬁned
as a continuant [snap:Continuant] that is dependent on some
other independent continuant [snap:IndependentContinuant]
bearer such that every instance of a generically dependent con-
tinuant D requires some instance of an independent continuant
C, but which particular instance of C serves as the bearer of D
can change from time to time [5]. For example, Leo Tolstoy’s no-
vel War and Peace (generically dependent continuant D) requires
instantiation in some paper or electronic bearer (e.g., a book or a
pdf ﬁle) C, but it is not particularly important for the existence of
the novel as such which particular bearer instantiates it. We will
elaborate in more detail on the use of BFO and its structure in
Section 3.Fig. 2. Relations between ACGT-speciﬁc classes and their superclasses from BFO.
Fig. 3. Resolving polysemy.Examples of representations of detailed, real world clinical trial
data are given in Section 6.2.1, where the Ontology-based Trial
Management Application is described.
Fig. 1 shows a number of examples linking objects and pro-
cesses from clinical reality to documentation items that are the re-
sults of these, as well as the subclass relation that each of these
entities (the objects, processes and documentation items) stand
into various BFO classes. Fig. 2 shows ACGT-speciﬁc relations as
sub-relations of relations imported to the ACGT-MO from an exter-
nal source.
All these pre-requisites make the ACGT-MO an application
ontology, one uniﬁed primarily by the goals or ends that it is de-
signed to achieve or facilitate.
In what follows, we will show how the practical constraints
introduced by real-world software development needs have inter-
acted in innovative ways with the design principles that we hold to
be necessary for high quality ontology development.2.3. Aim
The ACGT-MO is an application ontology and its main role, in
the context of the translational medicine research framework
Fig. 4. Disjointness violations in the ACGT-MO.
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gration across the borders of countries and disciplines, languages
and professional terminologies; as well as integration of newly
gathered data with data already stored.
As a result, the ACGT-MO is heavily used in the context of the
ACGT Semantic Mediation Process – the scientiﬁc details of which
are elaborated in Section 2.4. In speciﬁc, the two key systems
exploiting the MO are the ACGT Semantic Mediator (Section 6.1)
and the Ontology-based Trial Management Application (ObTiMA).
As for ObTiMA, the current version of the system aims to sup-
port clinical trial set up, design and managed. In this context, the
MO is utilized as a global schema for data annotation. We foresee
that Version 2 of ObTiMA will include decision support with re-
spect to many critical issues for clinical trial set up and manage-
ment. Such functional requirements are, nevertheless, out of
scope for the ACGT project and the development of this functional-
ity will go hand in hand with a process of ontology development
towards the needs of such services. As a conclusion, the ACGT-
MO does not aim to provide a comprehensive coverage of the com-
plete domain neither in terms of class coverage nor in terms ofFig. 5. TNM’s MX class.class deﬁnition. Thus the development of new services and the
expansion of the ontology itself are processes that will occur grad-
ually and in tandem.
2.4. TheACGT-MO andsemantic integration in the ACGT infrastructure
The requirements for the technical infrastructure of the ACGT
(the ACGT Platform) are that it be able to support the semantic
integration of heterogeneous data sources in cancer research and
management. These requirements have been met by designing a
federated environment, one that involves independent tools, com-
ponents and resources that have been developed based on open
architectural standards, and which are customizable and capable
of dynamic reconﬁgurations.
In deﬁning the initial architectural blueprint for such an envi-
ronment a layered approach was selected, one providing different
levels of abstraction and classiﬁcation of functionality into groups
of homologous software entities [6]. In specifying this architectural
blueprint for the ACGT Platform, similar speciﬁcations from other
relevant projects were thoroughly studied. Of particular relevance
are the Cancer Biomedical Informatics Grid (caBIG) in the US and
the CancerGrid project in the UK. One result of this is that the infra-
structure being developed for the ACGT Platform uses a set of ser-
vices and service registrations that are standard for the entire
community of cancer clinical trial research. Further, in our ap-
proach the required security services and components are in place
throughout the ACGT architecture so as to make available the user
management, access rights management and enforcement, and
trust bindings that are facilitated by Grid and domain-speciﬁc
security requirements like pseudonymization and anonymization.
As stated previously, one of the key scientiﬁc goals of the ACGT
is that of achieving semantic integration of heterogeneous, distrib-
uted and multilevel clinical and genomic data. Achieving this goal
is thus also one of the key scientiﬁc and technological challenges of
the ACGT. There are a number of different approaches to the
achievement of semantically consistent data integration. The main
methods fall into the following three categories: model alignment,
using semantic tags or metadata, and developing shared concep-
tual reference models or ontologies [7].
Fig. 6. ACGT-speciﬁc subclasses to Object within the BFO hierarchy.
Fig. 7. ACGT-speciﬁc subclasses to Process within the BFO hierarchy.
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models to support their semantic interoperability [8–10]. On this
approach, alignment is achieved by identifying a relationship di-
rectly between synonymous terms in different models, e.g., if ‘bio-
logical cell’ appears in one model and ‘cell’ appears in another,
where it is clear on investigation that these are intended to refer
to the same thing in the two different models, then a mapping is
established.
The second method is to use semantic tags or metadata [11],
such as those used by the Dublin Core Metadata Initiative [12].On this sort of approach, mappings are created not directly be-
tween data sources, but either between a data source and a meta-
data set or between different metadata sets.
The third approach is to develop a core ontology or ‘‘shared con-
ceptual reference model” to serve as the common ground for all of
the systems tobe integrated, and/or forpurposes of deﬁning a shared
metadata set [13–15]. This third approach ismore exact and central-
ized than the second, insofar as it provides a single frameof reference
towhich othermodels are to bemapped or, better, in terms ofwhich
entries in other models can be structured and deﬁned.
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tically consistent integration of multilevel biomedical data, the
ACGT project is pursuing – from among the various alternatives
just described – the third: the use of a shared conceptual reference
model or ontology. As a result, our semantic integration approach
requires the deﬁnition and integration of three main components,
which together comprise the core of the Semantic Mediation layer.
These components are (a) The ACGT Master Ontology on Cancer
(ACGT-MO) representing the shared conceptual model of the do-
main. (b) The mappings between ontology elements and data ac-
cess services schemas. (c) The Semantic Mediator (SM), a
software controlling the translation of queries and the integration
of results. Additional components that are used for overcoming
several issues in the data integration process are the Mapping Tool,
the Data Cleaning module (for retrieved instances), and the Query
Preprocessing Module (for literal homogenization in queries).
3. Principles guiding the development of the ACGT-MO
Ontology development is an activity that is constrained from
multiple directions and that is subject to multiple, sometimes con-
ﬂicting, demands: On the one hand, there are practical constraints
set by the function or service the ontology-driven system is in-
tended to achieve. On the other hand there are currently a growing
number of ontologies, many of which have overlapping or similar
contents and/or goals. The only way to ensure that ontologies in
the future will be able to keep their promise of unifying the seman-
tics underlying data organization and exchange in computer sys-
tems is to be aware of this situation and thus of the need to
continually work toward harmonization.
Keeping this in mind, the ACGT-MO has been developed on the
assumption that no new ontology should be developed if good pre-
existing ontologies already cover its intended domain. Thus, a de-
tailed and thorough review was conducted in order to determine
whether developing a new ontology from scratch would indeed
be necessary for achieving the goals of the ACGT project. This re-
view covered the Systemized Nomenclature of Medicine – Clinical
Terms (SNOMED-CT) [16], the Uniﬁed Medical Language System
(UMLS) [17], and the National Cancer Institute Thesaurus (NCIT)
[18] among others. Existing research literature on the ontology
underlying each of these resources was taken into consideration.
The conclusion reached was that none of the domain-speciﬁc ter-
minologies currently in existence would be used, since none of
them fully satisﬁed the quality criteria that have been adopted
by the ACGT developers, criteria that are further discussed below.
In order to provide an idea of the kinds of problems that were
discovered, some of the most severe issues identiﬁed with the
three resources mentioned above are listed here:
j SNOMED-CT:
s Multiple Inheritance (Example: Repair of inguinal hernia (pro-
cedure) (ConceptID: 44558001) is_a Inguinal region repair (pro-
cedure) (ConceptID: 120205009) & is_a Repair of hernia of
abdominal wall (ConceptID: 84744001) [19,20].
s UnknownX classes (Example: Unknown living organism (Con-
ceptID: 89088004) [19].
s Imprecise usage of the is_a relation (Example: Both testes (Con-
ceptID: 42774007) is_a Structure of bilateral paired structures
(ConceptID: 422525002). It is debatable whether both testes
of an individual form a structure; it might be safe to say they
form a set, though) [19,20].
j UMLS
s While the UMLS uses an Upper Ontology, it is reported to have
consistency problems with respect to keeping processes and
functions separate, in particular where processes executing
functions are involved [21].j NCIT
s Use of non-formal is_a relations (Example: Other Organism
Groupings is_a Organism) [18].
s NCIT lacks a coherent Upper Ontology. Biological Process and
Biological Function are synonymous in the thesaurus, and thus
would refer to the same set of individuals [22]. Furthermore,
there is no distinction between physical entities and realizable
entities (e.g., roles, functions), which leads to incoherent classi-
ﬁcations (Example: Infectious Agent: Virus is not a subclass of
Virus, but of Other Organism Groupings. Virus and Other Organism
Groupings are both subclasses of Organism [18].
Re-use of one existing ontology, namely the Foundational Mod-
el of Anatomy (FMA) [23] was approved, while the decision to re-
use the OBO Relation Ontology (RO) [24] was made both because
the OBO Relation Ontology is a high quality relation ontology by
current standards and because making use of the OBO Relation
Ontology is a pre-requisite for becoming a member of the OBO
Foundry [25], something which was part of the ACGT evaluation
strategy from the beginning (Section 5.3).
A virtue of these latter ontologies is that they stick to speciﬁc
well-deﬁned and explained methods of ontology development,
based on sound theoretical principles. For instance, they seek to
develop ontologies with a logical structure that can support algo-
rithmic processing, with a concern for the reality to which the
terms in an ontology relate (so that the ontology rests on a clear
distinction between entities in reality and the documents or data
entries used to represent them), and a concern for the interopera-
bility of the ontology being developed with other representations
of related domains of entities [26].
The basic principles and methods that have been selected and
employed in the development process of the ACGT-MO are the fol-
lowing, which are ﬁrst listed here, then subsequently explained in
greater detail below:
(1) Adopting a radically restrictive deﬁnition of the term
‘‘ontology”.
(2) Enforcing a strict subsumption hierarchy, based on a for-
mally speciﬁed is_a relation.
(3) Avoiding (non-trivial) multiple inheritance in the hierarchy
of universals.
(4) Avoiding ‘‘UnknownX” and related classes.
(5) Using an Upper Ontology, namely Basic Formal Ontology.
(6) Using OBO Relation Ontology (RO).
3.1. The adoption of a radically restrictive deﬁnition of the term
‘‘ontology”, in compliance with the principles of realism
The following deﬁnition of ‘ontology’ has recently been pro-
posed [27], and contains most of the crucial elements presupposed
by the ACGT-MO understanding of ontology: ‘‘an ontology is a rep-
resentational artifact whose representational units are intended to
designate universals in reality and the relations between them”.
This deﬁnition of an ontology has two parts. The ﬁrst identiﬁes
an ontology as a representational artifact consisting of representa-
tional units, while the second has to do with what the representa-
tional units in such an artifact are intended to refer to, namely
‘‘universals and relations between them” in reality. Here we will
ﬁrst say a few things about universals, then clarify the understand-
ing of ‘‘representational artifact” that is being employed.
To begin with universals: when a biologist studies an animal, a
particular cat for example, it is normally not because the biologist
is interested in the features of this very cat, but rather that she is
interested in the cat (and others like it that she may study) as in-
stances of a general kind, as being a potential source of information
about cats in general. It is normally this kind of general or abstract
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of philosophy and science, universals have been proposed and
understood as that which is general or abstract in reality; as the enti-
ties or principles that scientists are really seeking knowledge of
when they seek truths that apply to and explain all members of a
species or all kinds of DNA or all particles in the universe. Univer-
sals can thus be seen as a sort of theoretical explanation of the
structure, order and regularity that is to be found in nature, and
as what all members of a natural kind, grouping or species (such
as Oxygen or the cat just mentioned) have in common, at some le-
vel of abstraction. Universals are repeatable in the sense that they
can be instantiated by more than one object and at more than one
time (that they instantiate the universal ‘‘Cat” is what all particular
cats – cat1, cat2, cat3, etc. – have in common). As opposed to univer-
sals, particulars are the individual denizens of reality. Particulars
instantiate universals, but cannot themselves be instantiated, and
it is in virtue of instantiating the same universal that two particu-
lars will be similar in some respect (e.g., both being cats, both
being chromosomes, etc.). Universals can also be related to each
other in various ways. For example, the universal ‘‘Cat” is related
to the universal ‘‘Mammal” in the relation of species to genus, since
all cats are mammals.
Given all of this, saying that an ontology is a representation of
universals and relations between them in reality has a twofold pur-
pose. The primary purpose is to establish that an ontology is a
structured collection of information about kinds or types of things,
rather than about individuals. The goal of an ontology is ﬁrst and
foremost to codify and articulate relations between general truths
that apply to whole classes of things, not just to single individuals
or members of those classes in the world. The second purpose of
emphasizing the representation of universals in an ontology is to
stress the point that the representation of information about a
whole group or kind (universal) and the representation of informa-
tion about speciﬁc individuals (particulars) are different and
should be represented differently and kept separate in an ontology.
This is especially important in an application ontology such as the
ACGT, the goals of which will sometimes require representing spe-
ciﬁc individuals or institutions, as well as general or abstract kinds
of things.
Turning now to the notion of a representational artifact: a rep-
resentational artifact is an entity that makes pre-existing cognitive
representations from the minds of its author or authors publicly
available. Representational artifacts include things such as signs,
books, pictures and diagrams and have the key feature of including
ledgers or rules for their interpretation. Thus, maps do not simply
come color coded, they also come with a key or table that makes it
possible to interpret their color coding as representing certain
kinds of things (countries, oceans, mountain ranges, etc.), and the
words in which these tables and keys are written themselves have
publicly available rules for their interpretation as referring to
things in the world, namely the semantics of natural language it-
self. According to the above deﬁnition then, an ontology is just a
highly sophisticated kind of representational artifact. Viewing an
ontology in this way leads naturally to two ideas, both of which
have functioned as principles in the development of the ACGT-MO:
(i) When constructing a representational artifact for use in
science, such as an ontology, based on cognitive represen-
tations or concepts in the minds of individual subjects, the
goal is not to accurately represent in a publicly accessible
way the representations or concepts that exist in those indi-
vidual’s minds, but rather the things in reality that these
representations are representations of. Recognition of this
principle is also the point, in the above deﬁnition, of say-
ing that an ontology is a representation of universals in
reality.(ii) There is a fundamental distinction between using such arti-
facts to make reference to things in reality, i.e., the entities
that they are representations of (e.g., ‘‘cats are mammals”
or ‘‘Cancer is a disease”), on the one hand, and mentioning
such artifacts by engaging in discourse about them on the
other (e.g., ‘cat’ is a three letter English word or ‘Cancer’ is
a term deﬁned in the ACGT-MO). The construction of coher-
ent functional ontologies requires that this use-mention dis-
tinction be strictly consistently applied and respected.
The following is an example of a conﬂation of the use and the
mention of a term, taken from an old (and now corrected) deﬁni-
tion of ‘mouse’ in BIRNLex:
j ‘mouse’ is deﬁned as the ‘‘name for the species mus musculus”.
The problem with a deﬁnition such as this is that it provides
information about the word ‘mouse’, rather than information about
the biological species ‘‘mouse” in reality that is the intended object
of scientiﬁc study and discourse, thus mentioning the word rather
than using it. One goal major goal in the development of the ACGT-
MO has been to carefully avoid this sort of potential use-mention
confusion.
3.2. Enforcing a strict subsumption hierarchy, based on a formally
speciﬁed is_a relation, as opposed to a loose ‘‘subclass” hierarchy
The great majority of currently existing ontologies incorporate
relations that connect their terms (‘‘nodes”). Such relations, how-
ever, are sometimes being used in very informal ways, often pro-
viding no deﬁnitions at all, so that the resulting logical
interconnections are far from clear. Even the basic taxonomical
relation is_a (as in ‘‘Dolphin is_a Mammal”), the foundation of
any ontology, is not always used in a consistent or clear fashion.
A formal is_a relation should at the very least ensure that an in-
stance of a class is also an instance of its parent class (e.g., that if
Tibbles is an instance of the class/universal Cat, and Cat is_a Mam-
mal, then Tibbles is an instance of the class mammal), which is not
what always happens in the case of loosely deﬁned taxonomies as
encountered in many well-known contemporary ontologies, both
formal and domain-speciﬁc. Lassila [28] gives the following exam-
ple of this kind of inaccuracy, taken from Yahoo: ‘‘[. . .] the general
category apparel includes a subcategory women (which should
more accurately be titled women’s apparel) which then includes
subcategories accessories and dresses. While it is the case that
every instance of a dress is an instance of apparel (and probably
an instance of women’s dress), it is not the case that a dress is a
woman and it is also not the case that a fragrance (an instance of
a women’s accessory) is an instance of apparel. This mixing of cat-
egories such as accessories in web classiﬁcation schemes is not un-
ique to Yahoo – it appears in many web classiﬁcation schemes”.
While such inaccuracy may be tolerable in the context of shopping
for clothes, it seems much less tolerable in the context of serious
scientiﬁc and medical classiﬁcation and research, and it has been
strictly avoided in the development of the ACGT-MO.
3.3. Avoiding (non-trivial) multiple inheritance in the hierarchy of
universals
We also embrace the principle that a properly constructed
ontology should steer clear of an asserted taxonomical tree that al-
lows multiple parent classes for the same child class (i.e., one child
that inherits from multiple parents, so-called ‘‘multiple inheri-
tance”). The central aim is to avoid the polysemy, or assignment
of multiple meanings to a single term, that often results from
multiple inheritances. In the ACGT-MO we chose to deal with
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polysemic terms; e.g., Birth in natural language denotes, among
others, both the beginning of Life (a ProcessBoundary), and a Pro-
cess simpliciter – namely the very process of giving birth. The lat-
ter can also be encountered in the specialty literature under the
more speciﬁc term of Parturition (with proper part Labor), which
we chose to adopt, while leaving the term Birth under its former,
more common, reading (see Fig. 3).
Related to the multiple inheritance avoidance principle, we sub-
scribe to the principle according to which sibling classes in an
ontology should be disjoint. The principle of disjointness says that
two sibling classes should not share any members. In terms of
‘‘universals”, the principle says that a given particular cannot be
an instantiation of two sibling universals. This is one reason why
it is important to have the category Role in an ontology. If groups
like Physicians and Patients are primitive subclasses of the class Hu-
man Being it follows that a particular person cannot be both a phy-
sician and a patient. Nevertheless, we know that this occurs in
reality. Therefore it is important to represent Physician and Patient
as a Role that can be realized by a Human Being, thus avoiding mul-
tiple inheritance on the basis of a principled distinction between
individuals and the roles that they can, at various times, play or
take on.
An important exception to the disjointness rule has been toler-
ated in the ACGT-MO, due to circumstances relating to the map-
ping process. The architecture of the system built around the
ontology comprises, among others, several independently-devel-
oped cancer databases (breast cancer, nephroblastoma, Rhabdoid
tumor etc.), databases whose terms (ﬁelds, cells, records etc.) are
supposed to be mapped onto the ACGT-MO as part of the unifying
function of the ontology-driven system (the ‘‘mapping process”).
Querying the ontology (the SPARQL query language [29] has been
used for this) can thus be automatically translated/mapped into
querying the databases themselves. Unfortunately, the mapping
of SPARQL queries would have been considerably hindered by
the existence of OPTIONAL and FILTER blocks – blocks normally re-
quired by a deﬁnition of the PrimaryTumor class in terms of the
non-existence of tumors whose metastasis that primary tumor
is.2 We have, hence, opted to add both the PrimaryTumor and Metas-
tasis classes to the asserted taxonomy, even though this violates the
completeness desideratum often mentioned for clean ontology
development: aside from haematooncological tumors, all other tu-
mors (mixed, dysontogenic, neuroendocrine, carcinoma and sar-
coma) have both instances that belong in the PrimaryTumor class
and the Metastasis class (see Fig. 4). Note that the two classes, which
are not built according to the best practice, PrimaryTumor andMetas-
tasis, should ideally be conceived as roles.
It is also worth noting that as of this writing, the ACGT-MO in-
cludes rather few disjointness stipulations, as there is considerable
content-related debate in this respect; we do, however, expect that
further versions will make progress towards exhibiting disjoint
classes more fully and faithfully. Prompted by similar consider-
ations, we do not exclude further violations of the disjointness rule
in the future, even though we would prefer that the amount of
such exceptions be kept as low as possible.
3.4. Avoiding UnknownX and related classes
A common procedure among developers of medical databases,
terminologies, and ontologies, is the inclusion of classes of type
UnknownX, such as ‘‘UnspeciﬁedTumorStage” or ‘‘UnknownAfﬁlia-
tion”. ‘‘Universals” like these do not, however, have any instances,2 A FILTER directive, for example, is a SPARQL construct that speciﬁes that certain
classes are to be ignored/ﬁltered out from the results of the query.but merely indicate a lack of data or knowledge. Hence they repre-
sent an illegitimate epistemic intrusion into what should other-
wise constitute a faithful picture of reality, of what there is. The
alleged instances of these ‘‘universals” also do not exhibit any
shared properties, at least not in most cases, which further speaks
against treating them as genuine kinds or classes of things, scien-
tiﬁcally speaking. Still, daily clinical care cannot get by without
accounting for such lack of knowledge, e.g., to highlight that a cer-
tain test still needs to be done for a patient. Therefore information
models have to be created indicating the state of epistemic knowl-
edge (and ‘‘non-knowledge”) at some point in time, while their ac-
tual content can/should, in turn, be modeled based on ontological
classes and deﬁnitions. Hence if we provide classes only for reality
modeling but not for knowledge modeling, then the model would
need an additional source for performing the later. In order to
avoid this problem, while yet striving to anchor the master ontol-
ogy in reality as much as possible, we have opted to include some
minor epistemic classes via the import of well known and widely
used medical classiﬁcations like the German version of the TNM
[30].
Here (see Fig. 5) TNM’s MX class reads ‘‘Presence of distant
metastasis cannot be assessed”. It is important to note that
‘‘ClinicalClassTCM” is not an object-like entity but a subclass of
quality.3.5. Using an Upper Ontology, namely Basic Formal Ontology
The Standard Upper Ontology (SUO) working group of IEEE de-
ﬁnes Upper Ontology as follows:
An Upper Ontology is limited to concepts that are meta, generic,
abstract and philosophical, and therefore are general enough to ad-
dress (at a high-level) a broad range of domain areas. Concepts spe-
ciﬁc to given domains will not be included; however, this standard
will provide a structure and a set of general concepts upon which
domain ontologies (e.g., medical, ﬁnancial, engineering, etc.) could
be constructed [31].
Smith and Brochhausen [26] identify the use of an Upper Ontol-
ogy framework for reality representation as a basic harmonization-
fostering feature. Upper-level ontologies can provide not merely
basic categories and basic structure ensuring good ontology orga-
nization, but also a set of tested principles that can be re-used by
others in the development of speciﬁc domain ontologies.
For the ACGT-MO the project partners agreed to import Basic
Formal Ontology (BFO) [5], an ontology that is also an entry in
the OBO Foundry initiative [25]. The latter is a library of ontologies
built to meet the same set of quality criteria and to provide onto-
logical reference frameworks for different domains of the life sci-
ences [32].
The BFO taxonomy makes use of a basic top-level distinction
between two kinds of entities: substantial entities or continuants
(entities that endure through time while maintaining their iden-
tity) on the one hand, and occurrents or perdurants (entities that
happen, unfold, or develop in time) on the other. Corresponding
to these two kinds of entities are two basic and distinct perspec-
tives that can be taken on the world, neither of which can fully cap-
ture or represent the features of reality represented by the other:
these are the SNAP and SPAN perspectives or ontologies, respec-
tively [33]. For our present purposes, it sufﬁces to mention that
the SNAP ontology recognizes three major categories of continu-
ants: dependent continuants, independent continuants and spatial
regions, while SPAN includes processual entities and spatiotempo-
ral regions. Fig. 6 shows a ACGT-speciﬁc subclass structure sub-
sumed under the SNAP branch of BFO, while Fig. 7 gives depicts
a detail from the ACGT-speciﬁc subclass structure subsumed under
the SPAN branch of BFO.
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new relations/properties
The ACGT-MO not only represents classes as linked via the basic
taxonomical relation (‘‘is_a”), but it also connects them and/or re-
stricts their usage via other semantic relations called ‘‘properties”
in OWL terminology (e.g., connecting organs and their parts
through the parthood relation, and connecting processes and the
entities participating in them through the participation relation).
Speciﬁcally, the OBO Relation Ontology (RO) [24,34] has been used
as the basis for representing relations in ACGT because the RO has
been speciﬁcally developed to account for relations in biomedical
ontologies and includes clear and exact deﬁnitions specifying the
key logical features (transitivity, reﬂexivity, etc.) of most of the
relations it contains. In addition to the beneﬁt of having clearly de-
ﬁned and consistently used relations, using the RO for relation reg-
imentation is also part of the OBO Foundry criteria of ontology
excellence. The designers of the ACGT-MO have hence set as one
of their goals the inclusion of the ACGT-MO among OBO Foundry
ontologies.
As of October 2009, the RO comprises thirteen class-level rela-
tions [24]. While the ACGT-MO uses RO, its domain-speciﬁc
requirements call for more domain-speciﬁc relations than the RO
currently supplies. For this reason a number of additional relations
have had to be deﬁned in the ACGT-MO. In such cases, our goal has
been to approximate as closely as possible the clarity and logical
explicitness of the RO relations themselves. Table 1 gives examples
of non-RO relations in the ACGT-MO.
Due to the fact that the ACGT-MO is an application ontology
geared to the speciﬁc needs of the ACGT Semantic Mediation Ser-
vice and the ObTiMA service, no emphasis was laid on providing
fully deﬁned classes where representing contingent relations be-
tween classes was sufﬁcient to ensure the functionalities aimed
at. This is especially important for the way ontological annotations
for data are created via ObTiMA. This methodology is explained in
detail in Section 6.2.1. In effect the ACGT-MO contains 67 fully de-
ﬁned classes, among them the class ‘‘Disease”. The subclasses of
‘‘Disease” are represented with relations to other classes, but are
not fully deﬁned. How the relations and classes are used to create
uniﬁed annotations for clinical trial data is shown in detail in Sec-
tion 6.2.1.4. Maintenance of the ACGT-MO
The development of medical ontologies, such as the ACGT-MO,
reﬂects the rapid evolution of medical research as a whole. This
leads to the known problem of ontology evolution: on the one side,
ontologies need to be well-crafted and widely accepted by experts
in order to constitute the common agreement on semantics within
the operations of our information systems, on the other side there
is an urgent need for users to be able to use the latest terminology
in their ongoing research.Table 1
Non-RO relations in the ACGT-MO.
addedBy adds adverseReactionTo beginningOf
birthOf causedBy causes characterizedBy
characterizes compatibleWith contralateralTo denies
describedBy describes diagnosedBy diagnoses
examinedBy examines followUpOf fulﬁlledBy
hasAdverseReaction hasBeginning hasFollowUp hasHabit
hasHistory hasInﬂuenceOn hasInput hasLegalGuardian
hasMetastasis hasOutput hasProcessBoundary hasProtocol
hasQuality hasReason hasReceptor hasRelative
hasSymptom hasTherapyAim implementedBy implements
issuedBy issues patientAt picturedByThe ACGT Information Systems use the ACGT-MO as a built-in
semantic reference. The challenge is to be able to classify docu-
ments (clinical report forms, microbiological processes and ﬁnd-
ings, etc.) with the latest terminology even before it has been
widely approved, and nevertheless to evolve the MO as a stable ref-
erence consistent with all documents managed by the system. This
implies in particular a need for the ability to represent and retrieve
information accurately and precisely at any time.
Two main ontology maintenance processes are described in the
literature [35]:
(a) The scientiﬁc peer to peer review of concepts and their for-
mal description.
(b) The ‘‘democratic” evolution approach, resulting in so-called
folksonomies.
The ﬁrst is a re-active way to keep the ontology up-to-date.
Once a concept appears in use, i.e., in literature or databases, deci-
sions about its precise meaning and accepted use are made. These
decisions are usually made by a small group of ontology experts
whose knowledge of the ontology in question makes their inter-
pretation more or less ‘‘authoritative”. They maintain high quality
standards, but notoriously lag behind developments in the ﬁeld. In
folksonomies by contrast, anyone can introduce or change a con-
cept as needed. As a result of this, the ontology is always up-to-
date and reﬂects a sort of agreement (of the activists), but the
ontology usually lacks the formal consistency necessary for ad-
vanced reasoning and runs the risk of having other confusions
introduced.
In ACGT an innovative hybrid system was introduced, which
combines virtues from both approaches: registered users are al-
lowed to introduce (submit and use) any new class that they wish,
on the condition that it is declared as a specialization of some al-
ready authorized broader class. This guarantees that it will be pos-
sible to locate the newly classiﬁed content, which eventually
allows an expert team to take over the dialogue about the new
class and to make determinations about it, as well as to deal with
any content migration associated with it.
4.1. The ACGT Submission System
A major need of the ACGT community was to create a workﬂow
and communication system that would gather all the change re-
quests regarding the content of the ACGT-MO, feed them to the
ontology experts in a manageable way, keep the version history
of the ACGT-MO, and automate the communication back to the
interested parties of any changes taken place. These functional
requirements imply that the required information system should
have the ability to reclassify content or to rewrite queries involving
any authorized new expression that has replaced an old, an obso-
lete or a previously-used but currently rejected user-provided
term. To that end the ACGT Submission System was created. The
system is a re-active communication system allowing end-users
to criticize and/or submit their own opinion on the existing
ACGT-MO to its maintenance team.
The Submission System does not replace ontology development
systems such as ‘‘Protégé”. Rather, its role is to gather requests for
changes, assist the ontology expert by providing access to those re-
quests and by providing a point of reference for the changes in the
ontology, and to maintain previous ontology versions on a per-
class basis, including the history of related requests. The reason
for this is simply that previous classes, versions of or changes to
the ontology may well be of relevance in making future decisions
about what to include or whether or not to make a change. The
ACGT Submission System interfaces with an ontology development
system, here Protégé, to implement changes in a particular version
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in that version. It (semi-automatically) traces and registers the
changes made and relates them to previous versions of the ontol-
ogy, including changes to individual classes and requests for such
changes. The relatively loose coupling with Protégé has the advan-
tage of rendering the ACGT Submission System highly generic and
potentially useable with other ontology development systems in
the future (Protégé, even though quite popular, is not yet stable en-
ough to encourage a tighter coupling). The system manages the
workﬂow of processing requests, the details of decision-making,
and the necessary communications in order to minimize reliance
on manual checking and carrying out of these things by human
beings. It is inspired by the workﬂow patterns of well-known inter-
national thesaurus development teams such as the Getty Research
Institution or English Heritage.
The Submission System can be accessed by authorized users
independently through the Web or from within the ObTiMa Sys-
tem described in Section 6.2. Thus, ObTiMa users can add change
requests to the ACGT-MO directly from ObTiMa during the process
of document deﬁnition.
The ACGT Submission System distinguishes three user roles:
(a) The Contributor: A contributor to the system is a person who
wishes to comment or suggest changes to the ontology,
requesting additions/deletions or modiﬁcations of the exist-
ing ontology contents.
(b) The Domain Expert: The Domain expert contributes to the
system by reviewing the submissions of the Contributors
that concern their ﬁeld of expertise, and informs the Ontol-
ogy Experts of the necessary changes to the ontology.
(c) The Ontology Expert: The Ontology Expert is trained in logic
and formal ontologies and general possesses only minimal
domain knowledge. (S)he is responsible for the maintenance
of the ontology. (S)he receives all the change requests (sub-
missions), answers them or forwards them to a Domain
expert. This communication is automated to the highest
degree possible.
The ontology experts can browse through submissions, review
the submissions, discuss them with contributors and domain ex-
perts, and decide whether they agree or disagree with the pro-
posed changes, leading to either their implementation or their
rejection. Any rejection of a proposed change will be accompanied
by a declaration of how the correct meaning of a proposed class is
to be expressed by the MO (a migration path). In assistance, the
system provides the ontology expert with adequate information
services about all related class versions and submissions. The sys-
tem provides automatic feedback in the form of notiﬁcations to the
Contributors on the status of their submissions, and on the status
of the ontology. The system manages the publication of sets of
changes to the ontology on a release-by-release basis. A new re-
lease can be incorporated into the already running ACGT Informa-
tion Systems along with migration information.
4.2. The Submission Process
In this subsection the process following a new submission (see
Fig. 8) is described in more detail:
When inserting a new change request (submission) into the
System, the end-user automatically receives a notiﬁcation certify-
ing the submission. Once this is done, the new submission is in-
serted into the submission pool of the System. These new
submissions are sent via mail to the Ontology Expert (a team or
an individual), in order to inform her about the new change re-
quests, and the Ontology Expert can see the new submissions to
the system by logging into the system.In the sequence, the Ontology Expert reviews the new submis-
sion. The submission may be directly accepted, being seen as
redundant, or the Ontology Expert may need domain expert advice.
If it is accepted, the contributor receives a notiﬁcation. It is redun-
dant if it refers to something already covered by the MO. In such a
case it is rejected along with an explanation. If more domain exper-
tise is needed, the Ontology Expert sends the submission to the Do-
main Expert (a group or individual). The Domain Expert will be
informed via mail about the submission. After the Domain Expert
has checked the submission, he can either reformulate it and send
it back to the Ontology Expert or introduce an Implementation Pro-
posal for the request. Either way, the Domain expert sends the sub-
mission back and the Ontology Expert accepts, reject, or postpones
the submission and sends an answer, i.e., the way it will be imple-
mented or not implemented, to the Contributor.
At release time, all contributors are once again notiﬁed that their
accepted submissions have been released in an authorized version.5. Evaluation of the ACGT-MO
5.1. Criteria of ontology evaluation
Within ontology-driven computing there is a clear need to be-
gin focusing more heavily on ontology evaluation, particularly
since the spread of ontological engineering over the last years
has fostered the development of a multitude of ontologies, often
representing the same or similar domains. On the one hand it is
good to see that ontologies are becoming more and more a com-
mon solution for interoperability problems. On the other hand,
the vast number of ontology artifacts that are available leaves engi-
neers who are potentially interested in utilizing ontologies with
the problem of evaluating the different ontologies that are avail-
able, and of identifying the ontology that will be most appropriate
for their concerns. Yet, the development of shared standards for
evaluating ontologies seems to be moving rather slowly. Further-
more, the development of multiple domain ontologies that are
not interoperable with one another is a threat to the promise of
semantic interoperability held out by ontology-driven systems.
Ref. [36] provides a description of four different methodologies
for ontology evaluation. Yet, when it comes to evaluating the
usability of the methods themselves, the authors are merely check-
ing whether or not a methodology is actually in use, regardless of
the outcome it produces.
It is widely accepted that there is a central distinction to be
drawn between two different evaluation strategies, namely ‘‘glass
box” or ‘‘component” evaluation and ‘‘black box” or ‘‘task based”
evaluation. This distinction applies to evaluation processes for
ontologies and ontology-driven systems as well [36,37]. The two
strategies must be seen as complementary, each providing testing
for different kinds of signiﬁcant qualities.
Glass box evaluation is used for the evaluation of the ontology
as such, on its adequacy as a logically structured representation
of some domain of reality. It evaluates aspects such as domain cov-
erage, the ﬁtness of the ontology for a given task, and everything
that has to do with logical and structural virtues of the artifact at
hand, plus an assessment of the modules out of which the ontology
is built [37].
Hartmann et al. stress that glass box evaluating should start in
the design phase of an ontology (type 1), should accompany the
entire development process (type 2), and should continue after
the release of the ontology (type 3). Typically, type 1 and type 2
evaluations are done by the ontology engineer developing the arti-
fact in question, whereas type 3 evaluation is usually carried out by
ontology experts outside of the project [36]. Notably, there are no
domain experts or end-users involved in these activities.
Fig. 8. The Submission Process.
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were identiﬁed:
 Logical soundness;
 Domain coverage;
 Task orientation;
 Re-use of existing ontologies.
By contrast with glass box evaluation, black box evaluation fo-
cuses on the adequacy of the ontology as a functional computa-
tional system. It measures the performance of an ontology-driven
application and is typically carried out using the same interfaces
that the end-users are going to employ [36]. Gangemi et al. [37]
identify user-friendliness and agreement of domain experts as
quintessential measurements to be considered in black box evalu-
ations. Naturally, black box evaluation can be carried out by
end-users. In this paper we concentrate on reporting a glass box
evaluation technique used on the ACGT-MO and its results. Black
box evaluation ought to be carried out once the entirety of the
ACGT system is available.5.1.1. Logical soundness
With respect to ontology development it is crucial to check that
the ontology at hand does not contain any contradictory state-
ments. A contradiction free artifact is called consistent. The consis-
tency of the ACGT-MO is constantly and automatically checkedusing the Pellet reasoner application [38]. Constant consistency
checks during the development process are highly important in or-
der to facilitate troubleshooting, once inconsistencies occur, and to
facilitate the tracking down of erroneous logical deﬁnitions.
5.1.2. Domain coverage
Validating the domain coverage is crucial to ensuring the
usability of an ontology. There are a multitude of strategies for this
task. For the ACGT-MO we decided to automatically extract term
lists from domain-speciﬁc publications, namely journal articles
on clinical aspects of mamma carcinoma, Wilm’s tumor and rhab-
doid tumor. The text corpus used for NLP-based term extraction
consisted of slightly more than 3000 abstracts. The resulting term
list was then ﬁltered to eliminate non-domain-speciﬁc terms, and
the number of direct mappings was evaluated. Bearing in mind the
fundamental difference between terminology and ontology, it is
obvious that the direct mappings give only a hint regarding the ac-
tual completeness of domain coverage. Moreover, the study will
check to determine to what extent the ACGT-MO provides refer-
ence to the things designated by the terms extracted. This effort
is still ongoing and results will be published in parallel with this
paper.
5.1.3. Task orientation
The task orientation of the ACGT-MO was secured by a joint
development of the ontology with all applications of the ACGT
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ogy development principles and their speciﬁcations in Section 3
above indicates that compromises in favor of task orientation were
made when necessary. The way the MO deals with PrimaryTumor
and Metastasis in relation to the different pathological types of tu-
mors is a good example of this kind of task orientation (see Fig. 4
and the associated discussion in Section 3 above).
Another aspect is that the ACGT-MO needs to give relatively de-
tailed information about constraints, especially for some of the leaf
nodes. In order to supply the knowledge basis for creating, for in-
stance, Case Report Forms (CRFs) (as described below) it was
unavoidable to represent constraints with cardinality restriction
set to 0 (zero), e.g., Chemotherapy has Role min 0 AdjuvantChemo-
therapy. These kinds of constraints exhibit the high-level of task
orientation that has guided the development of the ACGT-MO.
5.1.4. Re-use of existing ontologies
The ACGT-MO re-uses three ontologies of the OBO Foundry [25],
which is a library of ontologies built to meet the same quality cri-
teria and to provide ontological reference for different domains of
the life sciences. The three ontologies are:
j Basic Formal Ontology (BFO) [5];
j Relation Ontology (RO) [27];
j Foundational Model of Anatomy (FMA) [23].
While the OWL implementations of BFO and RO are directly im-
ported into the OWL ﬁle of the ACGT-MO, this was not possible
with respect to the FMA. The reason for this was ﬁrst, that no ofﬁ-
cial version of the FMA in OWL existed when we started the devel-
opment (there were only two experimental conversions), and
second, that the sheer size of the FMA in its entirety was by far
too large (it was, e.g., impossible to apply the reasoner to the
FMA). The developers of the MO thus decided to include anatomi-
cal entities as they occurred in the documentation serving as a
blueprint for the targeted studies, and then to represent these in
a formal is_a hierarchy using the FMA as a model. The whole upper
structure of the ontological representation of anatomical entities in
ACGT-MO is thus effectively taken from the FMA.
5.2. The role of the OBO Foundry in the evaluation of the ACGT-MO
From the beginning the ACGT consortium planned to submit the
MO to the OBO Foundry in order to secure high quality in ontology
development and generate feedback from ontology experts. Most
of the criteria of the foundry are already fulﬁlled by the ACGT-
MO, while some others are the subject of ongoing work.
5.3. The use of the ACGT-MO outside the ACGT project
From the beginning the ACGT-MO developers followed strate-
gies of ontology development which state that it is vitally impor-
tant to treat ontology development as a scientiﬁc enterprise,
inviting critical discussion among experts to optimize the results
and stay clear of idiosyncratic solutions. In April 2009 the develop-
ers uploaded the ACGT-MO to the National Center for Biomedical
Ontology’s (NCBO) BioPortal [39]. Making it available for interested
domain experts and ontologists.
Even though the ACGT project is still ongoing, the ACGT-MO has
already experienced interest among other experts in the ﬁeld of
ontology-driven clinical data integration. In speciﬁc the ACGT-
MO is currently used by the Theseus medico project [40]. Publica-
tions on its use within that framework are under preparation. In
[41] the ACGT-MO is used as a possible bridging tool between
pre-existing health communication standards. Also, the ACGT-
MO is used to provide a middle layer for clinical disease manage-ment as a basis for disease speciﬁc sub-ontologies [42], within
the EU project CHRONIUS (FP7-ICT-2007-1-216461 – CHRONIOUS)
which focuses on chronic disease management.6. Exploitation of the MO in the ACGT project
The ACGT project is devoted to the development of a technolog-
ical infrastructure – namely, the ACGT Platform – aimed at assist-
ing clinicians, bioinformaticians and medical researchers involved
in cancer-related clinical trials in their data integration and analy-
sis tasks. The ACGT Platform is comprised of several services de-
signed to facilitate interaction between these groups. Two of
these services (the ACGT Semantic Mediator and the ObTiMA sys-
tem) require a semantic framework describing the domain of can-
cer for proper functioning. This semantic framework is in both
cases provided by the ACGT-MO. The next subsections describe
these components in some detail.
6.1. Semantic data integration in ACGT
6.1.1. Ontologies in database integration systems – background
Ontologies have been widely used in recent years to overcome
some of the difﬁculties encountered when integrating heteroge-
neous databases. In [43], Jakoniene and Lambrix describe speciﬁc
tasks in database integration that can beneﬁt from the use of ontol-
ogies, namely: (i) query formulation, (ii) query rewriting, and (iii)
data integration. In query formulation, ontologies can support
the process of query composition by providing human-under-
standable interfaces, alleviating end-users from having to learn
complex query languages. Examples of systems employing ontolo-
gies for such purposes can be found in [44] and [45]. Regarding the
query rewriting process, ontologies are employed to implement
schema mappings that allow overcoming the schema heterogene-
ities present in distributed sources. Queries in terms of a schema
can be effectively translated into queries for different schemas
using this approach. This is the case of systems such as ONTOFU-
SION [46] or SEMEDA [47]. Finally, ontologies can be used to solve
syntactic heterogeneities in order to correctly join data from heter-
ogeneous sources. Synonymy, granularity differences, or even scale
disparities are tackled prior to actual integration with the help of
ad hoc ontologies. This is the case in the CREAM framework [48],
COIN [49], or OntoDataClean [50].
6.1.2. Semantic Mediation
The ACGT Semantic Mediation (SM) Layer has the goal of pro-
viding clients with a seamless interface for integrated querying
of a number of heterogeneous data sources. This requires address-
ing the following challenges: (1) Post-genomic clinical trials com-
prise a dynamic data environment – i.e., new databases can arrive,
or existing ones can change; (2) databases present heterogeneities
at different levels – i.e., schema and instances; and (3) results are
presented in heterogeneous ways, without any type of annotation.
In order to overcome these problems, several approaches were
adopted. These approaches are described in the following sections.
6.1.3. Query processing
The query transformation approach adopted in ACGT is a difﬁ-
cult task that can be subdivided in a set of sub-problems to be ad-
dressed separately. Among the most important of these, we have
identiﬁed the following: (i) schema level heterogeneity, (ii) in-
stance level heterogeneity, (iii) performance in query translation
and results retrieval, (iv) complexity of the mapping process, and
(v) complex query constraints satisfaction [51]. The Semantic
Mediator tackles this process as follows: SPARQL was chosen as
the query language for the ACGT-SM. When a query is launched,
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Data Access Service (DAS). Each DAS returns the results in XML,
and the ACGT-SM integrates and annotates them to present a re-
sult set consistent with the original query. The ACGT-SM follows
a Local-as-view (LAV) based approach to solve the data integration
problem. The MO acts as the global schema in the mediation pro-
cess, so local views of the databases are deﬁned using its terminol-
ogy and relations. These local views maintain semantic and
syntactic homogeneity. However, LAV based approaches have
problems of scalability when translating the queries. Another prob-
lem when dealing with queries against integrated repositories is
the issue of identiﬁers heterogeneity. Queries can be formulated
using several literal identiﬁers expressing the same instance.
Hence, for a given query to be transformed, it must pass the ﬁlter
of the mapping – i.e., a set of correspondences between elements
from the databases to elements from the global schema. This ﬁlter
contains the information needed to translate the semantic infor-
mation present in the query – i.e., concepts and relations – into
the appropriate format.
The LAV semantic query translation process is a difﬁcult task
because of the possible incompleteness of the pre-deﬁned global
schema – i.e., the global schema is intended to describe the do-
main, but databases are not taken into account in its production
procedure – nor are the views deﬁning the underlying databases.
The process of ﬁnding the best query rewriting using local views
can be an NP-hard problem. This issue has been approached in sev-
eral projects [52,53], but the problem of scalability is still difﬁcult
to overcome. To this end, we propose to constrain the queries that
can be formulated by a single user, creating a personalized proﬁle
based on requirements gathered using examples.
Identiﬁers heterogeneity in queries is tackled using an ontol-
ogy-based solution. It makes use of an ontology that describes a
data-cleaning domain to let the user deﬁne the transformations
that must be applied on data. An additional module is responsible
for parsing and extracting the identiﬁers from SPARQL queries,
communicating them to the query cleaning system, and recompos-
ing the query with the new identiﬁers. In order to facilitate inter-
operability, the module is made accessible via a Web Service
interface. The ACGT-SM invokes this service before sending the
queries to the ACGT-DAS. Proper ontology instances need to be de-
ﬁned for each of the databases included in the integration schema.
This task can be performed along with the mapping process, and a
domain expert should be able to carry it out without the assistance
of an IT professional – using a dedicated tool, such as Protégé.
6.1.4. The mapping process
The goal of the mapping process is the production of a ‘‘map-
ping ﬁle” – i.e., a set of correspondences between the global sche-
ma and a given database schema. A correspondence is a pair of
semantically equivalent elements in both schemas. In the ACGT ap-
proach, the queries are built-in terms of the information contained
in the mapping ﬁles. In this case, the element used as global sche-
ma is the ACGT Master Ontology. Ontologies have been used for
semantic homogenization in mediation processes in several previ-
ous works [44,45,54,55].
The mapping process usually requires the involvement of a
team of experts in different domains. In a real case scenario, at
least the following proﬁles are needed: (i) a Master Ontology
authority, (ii) an expert in the database system to be mapped,
and (iii) a specialist in the mapping format and mediation process.
These three types of professionals collaborate in the deﬁnition of
semantic correspondences between the database schema and the
ontology. This can be a very complex task in the absence of dedi-
cated tools that leverage the processes of navigating the ontology,
identifying class level correspondences and creating entries in the
mapping language.The mapping process is a necessary step for adapting legacy
data sources, but the ultimate goal of ontology-based information
management is to enable the direct and transparent integration of
semantically heterogeneous data created in different environ-
ments (e.g., clinical research, laboratory data, etc.). ACGT aims to
provide solutions that demonstrate the possibility of collecting data
in an ontology-governed way. To explore this approach an ontol-
ogy-based Trial Management Application (ObTiMA) has been
developed, one that integrates the ACGT-MO already at the begin-
ning, in the design process of a clinical trial, in order to guarantee
that the data collected during the trial has comprehensive metada-
ta in terms of the ACGT-MOwithout the need to perform a separate
mapping process. We will describe ObTiMA in the following sec-
tion in more detail.6.2. ObTiMA – an Ontology-based Trial Management Application for
ACGT
ObTiMA [56] is an Ontology-based Trial Management Applica-
tion intended to help design and conduct clinical trials in an end-
user-friendly way. To support the whole life cycle of a clinical trial,
it utilizes the features provided by the ACGT-MO and the ACGT-SM.
In Fig. 9 the main components of ObTiMA, which are the Trial
Builder and the Patient Data Management System, and their inter-
action with the ACGT-SM are shown. The Trial Builder allows the
trial chairman to deﬁne the master protocol, the Case Report Forms
(CRFs) as well as the treatment plan for the trial, in a way that is
both semantically compliant with the ACGT-MO and user-friendly.
From these deﬁnitions, the Patient Data Management System can
be set up automatically in such a way that a medical clinician
can collect the patient data during the trial. The data collected in
the trial is stored in trial databases whose comprehensive metada-
ta has been rendered in terms of the ACGT-MO. The data can thus
be seamlessly integrated into the mediator architecture. It is
important to understand that in the ﬁrst version of ObTiMA the
ontology is not used for the purpose of decision support for clinical
trial development.
To provide a deeper understanding how we have achieved that
goal, in the following sections we will describe the various aspects
of ontology integration into ObTiMA in more detail. We will ﬁrst
describe how a trial can be set up in an ontology compliant way,
and then we will show how seamless data integration of the data
collected in the clinical trial can be performed and how the system
can handle the evolution of the ontology. We will then discuss the
advantages that ObTiMA gains from ontology integration when
compared with traditional trial management systems.6.2.1. Ontology-based trial set up
In the design phase of a trial ObTiMA allows a clinical trial
chairman to design both treatment plans which guide clinicians
through the treatment of a patient and CRFs to collect patient data
for full patient documentation. In this phase it is necessary that the
trial chairman deﬁnes all information to make data integration
possible i.e., an ontology description for each question on the
CRF and some metadata such as e.g., data type and measurement
unit to set up the trial databases. However, clinicians want to focus
on the user interfaces of the CRFs and try to integrate and adapt
them into the speciﬁc workﬂow of the clinical trial planned. They
should not be concerned with theoretical aspects and design prin-
ciples of databases or ontological metadata. In ObTiMA the trial
chairman can adapt the trial database for his trial and deﬁne onto-
logical metadata by creating the CRFs for his trials. Therefore, the
trial chairman can create the questions on the CRFs, which are also
called items in the following, from the ACGT-MO with the help of
the ‘‘Ontology Viewer”, a graphical user interface that depicts the
Fig. 9. Overview of ObTiMA.
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consists of the following sections (see Fig. 10):
 The Ontology View Section allows the selection of classes from
the ACGT-MO to describe an item in the clinical trial with a path
from the ontology. We have designed the Ontology View to
overcome the gap between clinical practice and biomedical
reality representation. Even if an ontology provides natural lan-
guage deﬁnitions for its entities and relationships (is, in other
words, ‘human understandable’) they are still deﬁned in a
way that is not based on practical or clinical perceptions of real-Fig. 10. Ontology Viewer during creation of item ‘‘Weight”: (1) Ontology View Section: O
(2) Item Creation Section: Type Value Item is selected and the attributes for question ‘‘
depicted.ity. In order to overcome this challenge, we provide an applica-
tion speciﬁc view of the ontology, a view that is meant to assist
clinicians in clinical practice. The starting point of each ontology
description is the class ‘‘Patient”, which is the focal point of each
CRF. To this end, when opening the Ontology View, the only
classes shown are those that can be related to the class patient,
such as e.g., ‘‘Weight” (indicating the patient’s weight) or
‘‘Tumor” (indicating the patient’s tumor). When selecting e.g.,
tumor, only classes that can be related with ‘‘Tumor”, such as
the ‘‘Laterality” (indicating the laterality of the patient’s tumor)
are shown.ntology description (described as ontological path) for patient’s weight is selected.
patient’s weight” are depicted. (3) Preview Section: Previews of different items are
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selected ontology description by selecting a question type,
which can be ‘‘Value Item”, ‘‘Multiple Choice Item” or ‘‘Exist
Item” (for descriptions see examples below). Only these ques-
tion types are enabled, which are sensible to create for the
selected ontology description. When an item type has been
selected, the attributes required in order to create the question
on the CRF are shown, e.g., the label, data type or answer possi-
bilities and a preview for the question is shown, where the
automatically created attributes can be manually adopted and
the item can be added to the Preview Section.
 In the Preview Section all created items are shown and the order
in which they shall appear on the CRF can be selected.
In our example, the clinician wants to create a query about the
patient’s weight (see Fig. 10). In the Ontology View Section he ﬁnds
a relation between the classes ‘‘Patient” and ‘‘Weight”. To create
the question he simply chooses the class ‘‘Weight” and an item
type. The user in our example creates a Value Item for his selected
ontology descriptions, which will query a ﬂoat value for the pa-
tient’s weight. The attributes required in order to create the ques-
tion on the CRF are then determined automatically, e.g., the label
and data type, and shown in the Item Selection Section.
Beside Value Items, which query number or string values for the
last class in the selected ontology description, it is possible to cre-
ate Multiple Choice and Exist Items in ObTiMA. Multiple Choice
Items are questions created from an ontology description of, for
example, a superclass, for which answer possibilities can be se-
lected from the ontology, for example, from amongst the subclas-
ses of the superclass. An example is the question ‘‘laterality of
nephroblastoma” with the answer possibilities ‘‘left”, ‘‘right” and
‘‘bilateral”. To create this question the user has to select the classes
‘‘Nephroblastoma” and ‘‘Laterality” in the Ontology View. When
creating a question of type Multiple Choice Item, the possible an-
swers are automatically determined from the ontology as ‘‘left”,
‘‘right”, ‘‘midline”, ‘‘bilateral”, ‘‘systemic” and ‘‘unknown” from
which the user can choose the desired ones.
Exist Items query whether an instance of a class in the ontology
description exists for the patient, an example is ‘‘Does patient have
a nephroblastoma” with answer possibilities ‘‘yes” and ‘‘no”.
Table 2 provides a real world examples of ontological paths se-
lected from the MO to represent the data collected for a speciﬁed
question in the CRF. The individual value for a patient is one in-
stance of the class speciﬁed. The examples are taken from the SIOP
Trial CRFs [4]. It is important to understand that the ontology is
used in ObTiMA to help the chair person develop the CRFs and to
ensure semantic interoperability of the data gathered at different
study sites with each other and with external resources.
6.2.2. Ontology-based data integration for cross-trial analysis
When the trial chairman decides the trial is ready to be con-
ducted, the form-based trial database and the data access services
are set up automatically from the deﬁnitions done in the design
phase. The mapping ﬁle (see Section 6.1), which contains the trans-
lation for the mediator to query the form-based databases in termsTable 2
Examples from the SIOP Trial for CRF questions and ontological paths. Note that for multis
classes she wants to provide as multiple-choice items.
Question on CRF Ontological p
‘‘Is the patient undergoing treatment as part of a clinical trial protocol
he/she is enrolled in?”
Patient under
ClinicalTrialPr
‘‘What is the tumor structure of the tumor in the patient’s kidney?” Patient hasPa
TumorHomog
‘‘At what date does radiotherapy start for the patient?” Patient underof the ontology, is created automatically and is sent to the media-
tor. While the trial is being conducted a clinician ﬁlls in the CRFs
for the patient, without being bothered about annotations from
the ontology. ObTiMA stores this ﬁlled in data in the trial database.
The mediator can, with the help of the mapping ﬁle, seamlessly
query the data of different clinical trials set up with ObTiMA and
other data sources in the ACGT mediator environment. Thus
cross-trial meta-analysis in terms of the shared ontology becomes
possible.
6.2.3. Ontology evolution in ObTiMA
In clinical trials new therapies or medicines are often intro-
duced, thus it is likely that ontology classes or relations necessary
to assemble queries for the CRFs are not yet represented in the
shared ontology. In Section 4.1 we have already described how
new classes and relations can be requested with the ontology sub-
mission system. It would, however, be tedious for the trial chair-
man to request a change in the submission system manually and
wait until the change has been accepted from an ontology expert
to be able to create his required question. Therefore, we have
implemented a direct interface between ObTiMA and the ACGT
Submission System, which allows the chairman of a clinical trial
to extend the ontology by creating the questions on the CRF, with-
out being interrupted in the design of the trial.
When the user observes that a class for creating a required
question is missing in the ontology, he can create a new class while
creating the question in the Ontology View Section. The newly cre-
ated class is stored as a temporary class in a local copy of the ontol-
ogy and can be used directly with the ontology description of the
question. ObTiMA automatically sends a request to the ontology
submission system to have the new class added to the shared
ontology. When the ontology expert accepts the request without
changes and releases a new version, ObTiMA automatically re-
places the local class in the ontology descriptions of the questions.
With the same mechanism temporary relations can be added dur-
ing the creation of a question.
The local copy of the ontology is always backwards compatible
to the current and to all previous versions of the shared ontology.
This approach assures that a trial containing temporary classes or
relations can already be queried with the current version of the
shared ontology by the mediator. Such mediator queries can even
include the data ﬁlled into items for which the ontology descrip-
tion contains temporary classes or relations, since they can be que-
ried with their super entities.
6.2.4. Advantages of ontology integration
Compared with traditional data management systems that lack
ontology support, ObTiMA has the following advantages:
– Built-in semantic interoperability between different trials
The procedure of ontology-based trial set up makes possible
the direct integration of the data collected in the clinical trial into
the semantics of the ontology. This means that data sharing be-
tween clinical trials and other data sources in the ACGT mediatorelection items the chairperson can select from the subclasses of the speciﬁed class all
ath Question type
goes TherapeuticProcess implements
otocol
Exist
rt Kidney has Part Neoplasm hasQuality
eneity
Multiselection with answer
possibilities x, y and z
goes Radiotherapy hasDate Date Value
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collected data for further research, such as cross-trial meta-anal-
ysis. ObTiMA promises to put an end to error-prone coding tech-
niques recently used to map clinical data onto biomedical
terminologies. Recent studies show that the accuracy of SNOMED
coding is only slightly over 50% given three different scenarios
[57,58].
– Increased quality of collected data
By using a shared ontology to create a data model, the collected
data becomes consistent with the knowledge of the underlying do-
main, which is coded in the ontology, and data quality increases.
Currently ObTiMA ensures, during creation of items, that only clas-
ses and relations from the ontology are chosen and that certain
restrictions from the ontology such as domain and range restric-
tions are satisﬁed. However, currently not all restrictions from
the domain ontology, as e.g., number restrictions, can be guaran-
teed automatically. Therefore, we are currently developing algo-
rithms to further improve data quality [59].
Nevertheless, ObTiMA has been designed to hide the details of
the ontology and the ACGT-SM from the user, enabling him or
her to concentrate on the workﬂow of the clinical trial, thus mak-
ing the system as user-friendly as possible. Furthermore, the
assembled ontology descriptions can be used to determine attri-
butes necessary for setting up the database, such as e.g., the data
types for items to be entered, and as a consequence enables the
user to set up the trial database in a way that is simultaneously
user-friendly and semantically compliant.
7. Discussion
7.1. Semantic Mediation in ACGT
The selection of the LAV approach was motivated mainly by the
nature of the domain, where the number of available databases
grows continuously [60]. This choice implies a relatively small ef-
fort when changes in the environment occur – i.e., new databases
need to be included, or existing databases change. However, deﬁn-
ing new views describing databases remains the bottleneck of the
data integration process.
From our point of view, LAV is the most appropriate choice gi-
ven the domain, but it leads to several issues that must be over-
come. One of these is the possible incompleteness of the global
schema, which is built without taking into consideration the
underlying databases. The ACGT-MO is built using CRFs belonging
to the initially selected clinical trials. In the case study, we encoun-
tered certain difﬁculties integrating a DICOM database – most of
the terms were present, but some of them not. The ACGT-SM al-
lows the utilization of several ontologies in deﬁning the view. This
feature can be used to solve this kind of added semantic heteroge-
neity. However, it is advisable to use only the ACGT-MO, in order to
avoid high complexity – mainly regarding query translation and
formulation.
In order to overcome the difﬁculties of query rewriting associ-
ated with the LAV approach, a novel method was proposed for cre-
ating user proﬁle-guided domain restrictions. This method makes
available only a subset of the global schema to the user, a subset
whose construction is based on pre-deﬁned user requirements.
The observed beneﬁt of this approach is twofold: (1) The query
translation process becomes simpler and (2) query formulation is
easier for end-users. However, this method presents one main
drawback: its high sensitivity to changes in the structure of the
integration – i.e., if new databases are added, or modiﬁcations oc-
cur in databases already integrated, then existing user proﬁles may
become invalid.7.2. Comparison of the ACGT strategy with the caBIG approach
Having presented the scientiﬁc and technical details of our ap-
proach, we feel that it is important to critically review current ef-
forts aimed at addressing similar problems which have adopted a
different approach to ours. The most prominent of such efforts is
the work of the cancer Biomedical Informatics Grid (caBIG), which
is being developed under the leadership of the National Cancer
Institute’s Center for Bioinformatics.
7.2.1. Overview of the caBIG data integration platform
caBIG [61] is a grid connecting individuals and institutions to
enable the sharing of data and tools. The goal is to speed the deliv-
ery of innovative approaches for the prevention and treatment of
cancer. caGrid [62] provides the core enabling infrastructure. It is
a service-oriented architecture and provides the implementation
of the required core services, toolkits and wizards for the develop-
ment and deployment of community provided services, APIs for
building client applications, and some sample client applications
for interacting with the current test bed installation. A particular
framework and set of tools provided by caGrid is the Cancer Com-
mon Ontologic Representation Environment (caCORE), which aims
to facilitate the creation of syntactically and semantically interop-
erable biomedical information services [63].caCORE deﬁnes a data
model speciﬁed using industry standard techniques to deﬁne com-
mon biological concepts. The main components of caCORE include:
– Cancer Bioinformatics Infrastructure Objects (caBIO): Platform
independent APIs that reﬂect an object-oriented view of bio-
medical information.
– Cancer Data Standards Repository (caDSR): A metadata registry
based upon the ISO/IEC11179 standard that is used to register
the descriptive information needed to render cancer research
data re-usable and interoperable.
– Enterprise Vocabulary Services (EVS): Controlled vocabulary
resources that support the life sciences domain, implemented
in a description-logics framework. EVS vocabularies provide
the semantic ‘raw material’ from which data elements, classes
and objects are constructed.
It is important to note that the EVS contains, among others, the
NCI Thesaurus, whose semantical vices and virtues have been thor-
oughly discussed in [22].
In caBIG a Model Driven Architecture (MDA) [64] is followed.
Following this approach, the designer uses the Uniﬁed Modeling
Language (UML) to create a graphical model of the functions, com-
ponents, and behavior of the system.
7.2.2. caBIG vs ACGT – the problem of metadata
In caBig the consistent use of metadata is secured by providing
a common meta-model built around the notion of (Common) Data
Elements. A data element consists of two parts, a Data Element
Concept (DEC) and a Value Domain (VD). The DEC is a formal
description of the thing about which we are recording a data value,
which is drawn from the Value Domain. Data Element Concepts are
further reﬁned into two subcomponents, Object Classes and prop-
erties. An Object Class is the entity that is being described by the
data element, while the property is a speciﬁc attribute of the entity
whose value is being recorded. Data Elements also have other asso-
ciated components, including a Representation which describes
the nature of the data that is being recorded (code, text, number)
and a Conceptual Domain, which is a means of classifying CDE
components (such as Data Element Concepts and Value Domains)
for easier search and identiﬁcation.
A ﬁrst main difference between the caBIG and the ACGT ap-
proaches is that in the case of ACGT no MDA and UML modeling
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sources. In ACGT there is no single registry for models e.g., to pre-
serve all the mappings and local schemas. Therefore the deﬁnition
of the local database schemas and the accompanied metadata
information are not ‘‘publicly” available in the same sense that ca-
BIG fosters reusability through the central metadata registry. In
ACGT the metadata deﬁnitions exist inside the ‘‘mapping ﬁles”
but the case of reusing these is irrelevant because the goal is to
integrate existing databases rather than designing and implement-
ing new ones based on what is already available.
Furthermore, in ACGT there is a single component (Semantic
Mediator) that is responsible for performing the data integration
in a transparent way through the appropriate query translations
based on the mappings of the local database schemas to the global
ACGT Master Ontology. This single authoritative query service al-
lows not only accessing the individual data services using a com-
mon terminology and query language, but also permits, unknown
to the user, the ‘‘fusion” of records coming from different databases
and a ﬁltering of the results based on the high-level user criteria. The
role of theACGTMasterOntology is, of course, critical to achieve this
level of integration and although caBIG uses the NCI Thesaurus and
Metathesaurus more or less for the same purposes, we argue that
starting with a formal ontology as a sound theoretical foundation
is superior [22]. Furthermore, once a stable and dependable seman-
tic resource is created, the project of providingmeta-models linking
and deﬁning the data elements can always be undertaken, whereas
high-level meta-modeling with an inconsistent semantic resource
remains likely to result in further inconsistencies and errors. We
hold that the value of the semantic integration in ACGT lies in the
fact that an ontology for cancer management is provided that satis-
ﬁes strict criteria for ontology development. In essence the ACGT ap-
proach is a more top down, uniﬁed, and ontology-based solution to
the semantic data integration problem.8. Conclusion
The development of the ACGT-MO is a clear-cut example of the
parallel development of an ontology and speciﬁc applications
within a major domain framework. We have shown that this strat-
egy leads to speciﬁc design decisions facilitating the use of the
ontology and assuring that the necessary amount of knowledge
is present in the ontology.
With respect to the relation between a knowledge management
system (in this special case a clinical information system) and an
ontology, the result is that reality-based ontology development is
no opposite to the development of a highly pragmatic information
system.9. Summary table
9.1. What was already known on the topic
 Principles of ontology development.
 Ontology maintenance and evaluation.
 Ontology-based clinical systems.
9.2. What the study added to our knowledge
 The study yielded a huge amount of experience in basing a
sophisticated knowledge sharing system on reality-based ontol-
ogy development.
 Interdependencies between ontology principles and needs of
the knowledge management system have been studied. Solu-
tions to reconcile user needs, technical requirements and theo-
retical coherence were achieved.Acknowledgments
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